{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:30:36Z","timestamp":1789831836833,"version":"4.0.1"},"reference-count":15,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,3,10]]},"DOI":"10.1253\/circrep.cr-24-0171","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:12:32Z","timestamp":1738620752000},"page":"176-182","source":"Crossref","is-referenced-by-count":3,"title":["Prefectural Survey on Immune Checkpoint Inhibitor-Associated Myocarditis at the Start of the Basic Plan to Promote Cancer Control Programs - Phase 4"],"prefix":"10.1253","volume":"7","author":[{"given":"Yuji","family":"Okura","sequence":"first","affiliation":[{"name":"Department of Onco-Cardiology, Niigata Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Niigata Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Health and Nutrition, Faculty of Human Life Studies, University of Niigata Prefecture"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Niigata City General Hospital"},{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kashimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Niigata Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Takenouchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Niigata Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Niigata Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"OCAN 2020 Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Jiji Medical Press. Cancer immunotherapy became one of the mainstays of treatment: 10 years since its domestic approval. August 15, 2024 (in Japanese). https:\/\/medical.jiji.com\/topics\/3564 (accessed January 28, 2025)."},{"key":"2","unstructured":"2. AnswersNews. Domestic pharmaceutical sales ranking for 2023. June 26, 2024 (in Japanese). https:\/\/answers.ten-navi.com\/pharmanews\/28186\/ (accessed January 28, 2025)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. <i>N Engl J Med<\/i> 2018; 378: 158\u2013168.","DOI":"10.1056\/NEJMra1703481"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y. et al. Fulminant myocarditis with combination immune checkpoint blockade. <i>N Engl J Med<\/i> 2016; 375: 1749\u20131755.","DOI":"10.1056\/NEJMoa1609214"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tajiri K, Ieda M. Cardiac complications in immune checkpoint inhibition therapy. <i>Front Cardiovasc Med<\/i> 2019; 6: 3.","DOI":"10.3389\/fcvm.2019.00003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, et al. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. <i>Eur J Cancer<\/i> 2022; 177: 197\u2013205.","DOI":"10.1093\/eurheartj\/ehac544.2562"},{"key":"7","unstructured":"7. Ministry of Health, Labor and Welfare. Basic Plan to Promote Cancer Control Programs: Phase 4. Cabinet decision report, March 28, 2023 (in Japanese) https:\/\/www.mhlw.go.jp\/content\/10901000\/001077913.pdf (accessed January 28, 2025)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. <i>J Clin Epidemiol<\/i> 2004; 57: 1096\u20131103.","DOI":"10.1016\/j.jclinepi.2004.04.005"},{"key":"9","unstructured":"9. Ministry of Health, Labor and Welfare. Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease: Phase 2. Cabinet decision report, on March 28, 2023 (inJapanese). https:\/\/www.mhlw.go.jp\/content\/10905000\/001077712.pdf (accessed January 28, 2025)."},{"key":"10","unstructured":"10. Japanese Society of Medical Oncology and Japanese Onco-Cardiology Society, editors. Onco-cardiology Guideline 1st edn. Tokyo: Nankodo; 2023 (in Japanese)."},{"key":"11","unstructured":"11. Ainger LE, Bushore J, Johnson WW, Ito J. Daunomycin: A cardiotoxic agent. <i>J Natl Med Assoc<\/i> 1971; 63: 261\u2013267."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). <i>Eur Heart J<\/i> 2022; 43: 4229\u20134361, Erratum in: <i>Eur Heart J<\/i> 2023; <b>44:<\/b> 1621.","DOI":"10.1093\/eurheartj\/ehad196"},{"key":"13","unstructured":"13. Oka T. Development of onco-cardiology in Japan. <i>Nihon Rinsho<\/i> 2024; 82: 19\u201325 (in Japanese)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Watanabe M, Fujiki S, Okura Y, Toshikawa C, Ikarashi M, Kanbayashi C, et al. Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: Thirty-one-year trends in a Japanese community. <i>Breast Cancer<\/i> 2024; 31: 1080\u20131091.","DOI":"10.1007\/s12282-024-01623-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okura Y, Ozaki K, Tanaka H, Takenouchi T, Sato N, Minamino T. The impending epidemic of cardiovascular diseases in patients with cancer in Japan. <i>Circ J<\/i> 2019; 83: 2191\u20132202.","DOI":"10.1253\/circj.CJ-19-0426"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/3\/7_CR-24-0171\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:26:48Z","timestamp":1742009208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/3\/7_CR-24-0171\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-24-0171","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"article-number":"CR-24-0171"}}